ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Jpm Ust 0-1 Etf

Jpm Ust 0-1 Etf (MBIL)

92,365
0,00
( 0,00% )
Mis à jour : 02:00:00

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
92,365
Prix Achat
92,31
Prix Vente
92,42
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
92,365
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

MBIL Dernières nouvelles

Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors

PORT HUENEME, CA -- (Marketwired) -- 09/25/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is very pleased to announce the appointment of...

Stellar Biotechnologies Closes US$12 Million Private Placement Financing

PORT HUENEME, CA -- (Marketwired) -- 09/23/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today, further to its news releases of...

Stellar Biotechnologies Raises US$10 Million in Initial Closing of Private Placement

PORT HUENEME, CA -- (Marketwired) -- 09/10/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that, further to its news release of...

Stellar Biotechnologies to Present at Rodman and Renshaw 13th Annual Global Investment Conference From September 8-10, 2013

PORT HUENEME, CA -- (Marketwired) -- 08/29/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that it will present at the Rodman...

Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement

PORT HUENEME, CA -- (Marketwired) -- 08/22/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announces its intent to close a private placement of...

Stellar Biotechnologies Issues President's Letter to Shareholders

PORT HUENEME, CA -- (Marketwired) -- 08/06/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is pleased to announce that it has issued a letter...

Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology

PORT HUENEME, CA -- (Marketwired) -- 07/30/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that the Company has acquired the...

Stellar Biotechnologies Announces Joint Research on Clostridium Difficile Immunotherapy Accepted for Presentation

PORT HUENEME, CA -- (Marketwired) -- 07/24/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that a preclinical abstract on...

Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference

PORT HUENEME, CA -- (Marketwired) -- 05/28/13 -- Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at the...

Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference

PORT HUENEME, CA -- (Marketwired) -- 05/21/13 -- Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein, Executive...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock